Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:protocol:olmesartan [02.25.2019] – [Kidney disease] sallieqhome:protocol:olmesartan [04.20.2019] – [Other beneficial effects] sallieq
Line 123: Line 123:
   * inhibit liver fibrosis and aid liver healing(({{pubmed>long:12871826}}))   * inhibit liver fibrosis and aid liver healing(({{pubmed>long:12871826}}))
   * reduce insulin resistance in rats(({{pubmed>long:15127887}}))   * reduce insulin resistance in rats(({{pubmed>long:15127887}}))
-  * 6 mg/kg olmesartan reduces the inflammatory process and bone loss in rats(({{pubmed>long:23775504}}))+  * 6 mg/kg olmesartan reduces the inflammatory process and periodontal bone loss in rats(({{pubmed>long:23775504}}))      
   * protect the mitochondria from age-associated damage from oxidation(({{pubmed>long:12709417}}))   * protect the mitochondria from age-associated damage from oxidation(({{pubmed>long:12709417}}))
   * play a protective role against proliferative diabetic retinopathy (({{pubmed>long:17560613}}))   * play a protective role against proliferative diabetic retinopathy (({{pubmed>long:17560613}}))
home/protocol/olmesartan.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.